Journal
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
Volume -, Issue 175, Pages -Publisher
JOURNAL OF VISUALIZED EXPERIMENTS
DOI: 10.3791/63094
Keywords
-
Categories
Funding
- Industrieel OnderzoeksFonds/Strategisch Basisonderzoek (IOF/SBO) research grant [PID34923]
- Geconcerteerde Onderzoeksactie (GOA) grant of the University of Antwerp [PID36444]
- Fund for Scientific Research Flanders [1842219N, G021019N, G0D0520N, G021420N]
- ERA.Net RUS Plus [278]
- Vlaamse Interuniversitaire Raad/Interuniversitair Bijzonder OnderzoeksFonds (VLIR/iBOF) [20-VLIR-iBOF-027]
Ask authors/readers for more resources
This paper presents a model of sterile pericarditis-induced atrial myopathy in Aachener minipigs, which has clinical relevance, necessary features, and reproducibility.
Atrial fibrillation (AF) is the most common arrhythmia caused by structural remodeling of the atria, also called atrial myopathy. Current therapies only target the electrical abnormalities and not the underlying atrial myopathy. For the development of novel therapies, a reproducible large animal model of atrial myopathy is necessary. This paper presents a model of sterile pericarditis-induced atrial myopathy in Aachener minipigs. Sterile pericarditis was induced by spraying sterile talcum and leaving a layer of sterile gauze over the atrial epicardial surface. This led to inflammation and fibrosis, two crucial components of the pathophysiology of atrial myopathy, making the atria susceptible to the induction of AF. Two pacemaker electrodes were positioned epicardially on each atrium and connected to two pacemakers from different manufacturers. This strategy allowed for repeated non-invasive atrial programmed stimulation to determine the inducibility of AF at specified time points after surgery. Different protocols to test AF inducibility were used. The advantages of this model are its clinical relevance, with AF inducibility and the rapid induction of inflammation and fibrosis-both present in atrial myopathy-and its reproducibility. The model will be useful in the development of novel therapies targeting atrial myopathy and AF.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available